That dynamic shifted in 2024, when Wegovy gained an indication for reduced cardiovascular risk in March and Zepbound added an OSA indication in December
And with the right combination of nutrition, exercise, and supportive therapies, patients can preserve lean mass while still benefiting from the powerful fat-reducing effects of these medications
Appetite Suppression : Mounjaro curbs your cravings, making it easier to resist unhealthy snacks and overeating
Semaglutide, on the other hand, has demonstrated substantial and sustained weight loss in clinical trials, thanks to its ability to influence appetite control and energy balance directly
Retatrutide is expected to complete its Phase 3 TRIUMPH program in 2026
The tool then subtracts these values from monthly income to estimate a discretionary health budget